Log in to add comments or register here

Science News from the American Heart Association

We turn American Heart Association's Science News into an interactive format for you. Find something interesting or have a question? Let us know in the comments.

Science News from ESC Congress 2010: SUNDAY

Sunday Science News from the European Society of Cardiology Congress 2010:

Commentary on Sunday's Hot Lines

AHA/ASA volunteer Mariell Jessup, MD, FAHA discusses the Hot Lines presented today at ESC Congress 2010.
Video interview

Latest Breaking Clinical Science

	SHIFT: Effects of ivabradine on CV events in HF Prof. Michel Komajda, Paris, FR Presentation Slides \| Study Results Rationale and design of the SHIFT study: View article Interview with Dr. Komajda on the Centre in Paris: View Circulation article
	The STAR Heart Study: Promising results for intracoronary stem cell transplantation Prof. Bodo-Eckehard Strauer, Duesseldorf, DE Summary Slide View article (European Journal of Heart Failure)
	ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients Prof. Daan Kromhout, Wageningen, NL Summary Slide Publication in NEJM
	HEBE III: A single dose of erythropoietin in ST-elevation myocardial infarction Prof. Adriaan Voors, Groningen, NL Presentation Slides Abstract in European Heart Journal

Hot Line I: Presentation Details (PDF): View presentation details for all Hot Lines presented Sunday, Aug. 29, 2010 at ESC Congress.

Clinical Trial Updates
CURE ACTIVE: Efficacy and Safety of Clopidogrel compared with Placebo according to CYP2C19 Genotype

Guillaume Paré, Hamilton, CA
Publication in NEJM

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms: a genetic substudy of the PLATO trial

Lars C. Wallentin, Uppsala, SE

Publication in Lancet

Posted by Molly AHA Science on Aug 30, 2010 10:48 AM CDT

Flag

Comments

see more comments

Cheryl Perkins

Date Posted: Aug 29, 2010 at 1:16 PM

This first day of ESC has some exciting science news! • Adding bone marrow stem cell therapy to conventional therapy for chronic heart failure – does it improve survival? • Will low-dose omega-3 fatty acids reduce the rate of major coronary events following an MI? • Will these and other results impact clinical practice? Here’s our chance for some pro and con discussion to consider other perspectives. Cheryl Perkins, M.D., RPh AHA Science and medicine Advisor

Flag

Network Navigation

You must be logged in to comment on blogs.

You are not currently logged in.

Don't already have an account on My.AmericanHeart.org?